bluebird bio, Inc. Deferred Tax Assets, in Process Research and Development
bluebird bio, Inc. had Deferred Tax Assets, in Process Research and Development of $99.91 million as of 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2025-03-27
- 2024-12-31: Deferred Tax Assets, in Process Research and Development $99.91M.
- 2023-12-31: Deferred Tax Assets, in Process Research and Development $91.31M.
- 2022-12-31: Deferred Tax Assets, in Process Research and Development $54.88M; Deferred Tax Assets, in Process Research and Development as first filed $51.51M.
- 2021-12-31: Deferred Tax Assets, in Process Research and Development $0.00.
| Period end | Deferred Tax Assets, in Process Research and Development | Deferred Tax Assets, in Process Research and Development as first filed |
|---|---|---|
| 2024-12-31 | $99.91M 10-K · filed 2025-03-27 | |
| 2023-12-31 | $91.31M 10-K · filed 2025-03-27 | |
| 2022-12-31 | $54.88M 10-K · filed 2024-09-13 | $51.51M 10-K · filed 2023-03-29 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-29 |